Hypoxia-induced BAX overexpression and radiation killing of hypoxic glioblastoma cells

Radiation Research

Volumn 163, Issue 6, 2005, Pages 644-653

  Chen, Jennifer K ^a   Hu, Lily J ^a   Wang, Jingli ^a   Lamborn, Kathleen R ^a   Kong, Eileen L ^a   Deen, Dennis F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN BAX;

APOPTOSIS; ARTICLE; CELL CLONE; CELL KILLING; CELL LINE; CELL STRAIN U 251 MG; CELL STRAIN U 87 MG; CELL SURVIVAL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RADIATION DOSE; RADIOSENSITIVITY; WESTERN BLOTTING; X RAY;

ADAPTATION, PHYSIOLOGICAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLIOBLASTOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION DOSAGE; RADIATION TOLERANCE; RECOMBINANT PROTEINS;

MURINAE;

EID: 19544364658     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3377     Document Type: Article

References (38)

1. J. R. Simpson, J. Horton, C. Scott, W. J. Curran, P. Rubin, J. Fischbach, S. Isaacson, M. Rotman, S. O. Asbell and D. E Nelson, Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26, 239-244 (1993).
2. M. S. Berger and C. B. Wilson, Eds., The Gliomas. W. B. Saunders, Philadelphia, 1999.
3. J. B. Fiveash and S. A. Spencer, Role of radiation therapy and radiosurgery in glioblastoma multiforme. Cancer J. 9, 222-229 (2003).
4. J. M. Brown, The hypoxic cell: A target for selective cancer therapy - eighteenth Bruce F. Cain memorial award lecture. Cancer Res. 59, 5863-5870 (1999).
5. E. J. Hall, Radiobiology for the Radiologist, 5th ed. Lippincott Williams & Wilkins, Philadelphia, 2000.
6. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29, 427-431 (1994).
7. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz and M. W. Dewhirst, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943 (1996).
8. M. Hockel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509-4515 (1996).
9. A. L. Harris, Hypoxia - a key regulatory factor in tumor growth. Nat. Rev. Cancer 2, 38-47 (2002).
10. O. Cuisnier, R. Serduc, J. P. Lavieille, M. Longuet, E. Reyt and C. Riva, Chronic hypoxia protects against gamma-irradiation-induced apoptosis by inducing bcl-2 upregulation and inhibiting mitochondrial translocation and conformational change of bax protein. Int. J. Oncol. 23, 1033-1041 (2003).
11. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe and A. J. Giaccia, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
12. B. Antonsson and J. C. Martinou, The bcl-2 protein family. Exp. Cell Res. 256, 50-57 (2000).
13. Q. Chen, B. Gong and A. Almasan, Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ. 7, 227-233 (2000).
14. M. Nomura, S. Shimizu, T. Ito, M, Narita, H. Matsuda and Y. Tsujimoto, Apoptotic cytosol facilitates bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res. 59, 5542-5548 (1999).
15. S. Kitada, S. Krajewski, T. Miyashita, M. Krajewska and J. C. Reed, Gamma-radiation induces upregulation of bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12, 187-92 (1996).
16. H. K. Shu, M. M. Kim, P. Chen, F. Furman, C. Julin and M. A. Israel, The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21BAX expression. Proc. Natl. Acad. Sci. USA 95, 14453-14458 (1998).
17. T. Ohno, T. Nakano, Y. Niibe, H. Tsujii and K. Oka, Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma. Cancer 83, 103-110 (1998).
18. C. Sakakura, E. A. Sweeney, T. Shirahama, Y. Igarashi, S. Hakomori, H. Nakatani, H. Tsujimoto, T. Imanishi, M. Ohgaki and T. Takahashi, Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer 67, 101-105 (1996).
19. C. Sakakura, E. A. Sweeney, T. Shirahama, Y. Igarashi, S. Hakomori, H. Tsujimoto, T. Imanishi, M. Ohgaki, J. Yamazaki and T. Takahashi, Overexpression of bax enhances the radiation sensitivity in human breast cancer cells. Surg. Today 27, 90-93 (1997).
20. J. R. Streffer, A. Rimner, J. Rieger, U. Naumann, H. P. Rodemann and M. Weller, Bcl-2 family proteins modulate radiosensitivity in human malignant glioma cells. J. Neurooncol. 56, 43-9 (2002).
21. W. O. Arafat, J. Gomez-Navarro, J. Xiang, M. N. Barnes, P. Mahasreshti, R. D. Alvarez, G. P. Siegal, A. O. Badib, D. Buchsbaum and M. A. Stackhouse, An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Mol. Ther. 1, 545-554 (2000).
22. W. O. Arafat, D. J. Buchsbaum, J. Gomez-Navarro, S. A. Tawil, C. Olsen, J. Xiang, H. El-Akad, A. M. Salama, A. O. Badib and D. T. Curiel, An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 55, 1037-1050 (2003).
23. H. Ruan, J. Wang, L. Hu, C. S. Lin, K. R. Lamborn and D. F. Deen, Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX. Neoplasia 1, 431-437 (1999).
24. H. Ruan, L. Hu, J. Wang, T. Ozawa, N. Sanai, M. Zhang, K. R. Lamborn and D. F. Deen, Hypoxia-inducible expression of BAX: Application in tumor-targeted gene therapy. Neurosurg. Focus 8, 1-7 (2000).
25. H. Ruan, H. Su, L. Hu, K. R. Lamborn, Y. W. Kan and D. F. Deen, A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 3, 255-263 (2001).
26. B. Endlich, I. R. Radford, H. B. Forrester and W. C. Dewey, Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat. Res. 153, 36-48 (2000).
27. N. Gupta, K. Lamborn and D. F. Deen, A statistical approach for analyzing clonogenic survival data. Radiat. Res. 145, 636-640 (1996).
28. T. Strobel, L. Swanson, S. Korsmeyer and S. A. Cannistra, Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells. Oncogene 14, 2753-2758 (1997).
29. C. M. Knudson, K. S. Tung, W. G. Tourtellotte, G. A. Brown and S. J. Korsmeyer, Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
30. L. Rieger, M. Weller, A. Bornemann, M. Schabet, J. Dichgans and R. Meyermann, BCL-2 family protein expression in human malignant glioma: A clinical-pathological correlative study. J. Neurol. Sci. 155, 68-75 (1998).
31. E. W Newcomb, H. Cohen, S. R. Lee, S. K. Bhalla, J. Bloom, R. L. Hayes and D. C. Miller, Survival of patients with glioblastoma multiforme is not influenced by altered expression of p 16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol. 8, 655-667 (1998).
32. M. Kuwabara, K. Takahashi and O. Inanami, Induction of apoptosis through the activation of SAPK/JNK followed by the expression of death receptor fas in X-irradiated cells. J. Radiat. Res. 44, 203-209 (2003).
33. R. A. Ihrie and L. D. Attardi, Perpetrating p53-dependent apoptosis. Cell Cycle 3, 267-269 (2004).
34. L. D. Attardi, E. E. Reczek, C. Cosmas, E. G. Demicco, M. E. McCurrach, S. W. Lowe and T. Jacks, Perp, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14, 704-718 (2000);
35. Erratum, Genes Dev. 14, 1835 (2000).
36. N. Shinoura, Y. Yoshida, A. Asai, T. Kirino and H. Hamada, Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of bax. Oncogene 18, 5703-5713 (1999).
37. J. T. Erler, C. J. Cawthorne, K. J. Williams, M. Koritzinsky, B. G. Wouters, C. Wilson, C. Miller, C. Demonacos, I. J. Stratford and C. Dive, Hypoxia-mediated downregulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell Biol. 24, 2875-2889 (2004).
38. V. Lebedeva, D. Sarkar, Z. Z. Su, S. Kitada, P. Dent, C. A. Stein, J. C. Reed and P. B. Fisher, Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 22, 8758-8773 (2003).